Skip to main content
. 2019 May 13;11:4437–4448. doi: 10.2147/CMAR.S201424

Figure 1.

Figure 1

Study design. The control group (n=6) was treated with SOR without DBB or HIS. The DBB+SOR group (n=6) and the HIS +S OR group (n=6) were treated with SOR with DBB and SOR with HIS.

Abbreviations: SOR, sorafenib; DBB, dried bonito broth; HIS, histidine; CT, computed tomography.